Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Retained Earnings (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Retained Earnings for 8 consecutive years, with -$6.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 100.83% to -$6.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.4 million, a 100.83% decrease, with the full-year FY2025 number at -$6.4 million, down 100.83% from a year prior.
  • Retained Earnings was -$6.4 million for Q4 2025 at Select Medical Holdings, down from $824.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $1.1 billion in Q3 2024 to a low of -$6.4 million in Q4 2025.
  • A 5-year average of $530.7 million and a median of $632.4 million in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: surged 1584.0% in 2024, then tumbled 100.83% in 2025.
  • Select Medical Holdings' Retained Earnings stood at $593.3 million in 2021, then decreased by 2.06% to $581.0 million in 2022, then grew by 29.41% to $751.9 million in 2023, then rose by 2.43% to $770.1 million in 2024, then crashed by 100.83% to -$6.4 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Retained Earnings are -$6.4 million (Q4 2025), $824.8 million (Q3 2025), and $804.7 million (Q2 2025).